Vernalis Research - a Fully Owned Subsidiary of HitGen Inc - and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS
Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Hannibal Innovation ApS ("Hannibal") are pleased to announce the creation of Dania Therapeutics ApS ("Dania") to discover
Source: finanznachrichten.de